New antibiotics are emerging from the innovative research conducted by Kinvard Bio, a Harvard startup that aims to combat the rising threat of drug-resistant infections.As antibiotic resistance becomes a critical global health crisis, new strategies are urgently needed to effectively address diseases caused by resilient bacteria.